Enquiry/Quote
Vimseltinib bulk supplier for pharma manufacturers

Vimseltinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 14 mg; 20 mg; 30 mg

Reference Brands: Romvimza

Category: Oncology Cancer Care

Vimseltinib is used in adults to treat giant cell tumor of the tendon sheath (also called tenosynovial giant cell tumor) that is not likely to improve with surgery. Before taking this medicine, tell your doctor if you have or have ever had an allergy to aspirin or food dye or liver disease. Vimseltinib can harm an unborn baby if the mother or the father is using vimseltinib.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide

Product Description:

Vimseltinib, an investigational oncology drug, is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality according to GMP standards. In the US, regulatory review involves validation, safety assessments, and clinical trial data submission. In the EU, approval processes include validation, stability testing, and conformity with MDR standards. These dossiers encompass safety profiles, clinical trial results, and manufacturing practices

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Vimseltinib is used for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgical removal of the tumor would cause severe complications or functional disability. It works by blocking the CSF1R receptor, which helps reduce the growth and spread of tumor cells in the affected joints or tissues.

Vimseltinib is a small-molecule compound formulated as oral capsules. It contains the active ingredient vimseltinib, a selective colony-stimulating factor 1 receptor (CSF1R) inhibitor. The capsules also include inactive ingredients such as lactose monohydrate, crospovidone, and magnesium stearate.

The trade name of Vimseltinib is Romvimza.

Vimseltinib is developed and manufactured by Deciphera Pharmaceuticals, LLC, which is part of the Ono Pharmaceutical Group.

The generic name of the product is Vimseltinib.

The brand name of the product is Romvimza.

Vimseltinib (Romvimza) is manufactured by Deciphera Pharmaceuticals, LLC at its facility in Waltham, Massachusetts, USA.

Related Products

Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Idelalisib

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Zydelig (EU/UK/India)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.